Jonathan N Hofmann1, Douglas A Corley, Wei K Zhao, Joanne S Colt, Brian Shuch, Wong-Ho Chow, Mark P Purdue. 1. From the aOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; bDivision of Research, Kaiser Permanente Northern California, Oakland, CA; cDepartment of Urology, Yale School of Medicine, New Haven, CT; dDepartment of Epidemiology, The University of Texas, Houston, TX; and eOntario Institute for Cancer Research, Toronto, ON, Canada.
Abstract
BACKGROUND: The incidence of renal cell carcinoma in the United States differs by race/ethnicity. To better understand these disparities, we conducted a nested case-control study investigating renal cell carcinoma risk factors across racial/ethnic groups within the Kaiser Permanente Northern California health care network. METHODS: Our study included 3136 renal cell carcinoma cases (2152 whites, 293 blacks, 425 Hispanics, and 255 Asians) diagnosed between 1998 and 2008 and 31031 individually matched controls (21478 whites, 2836 blacks, 4147 Hispanics, and 2484 Asians). Risk of renal cell carcinoma was assessed in relation to smoking status, body mass index (BMI), hypertension, and chronic kidney disease. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using conditional logistic regression, and population attributable risk (PAR) to estimate by race the proportion of cases attributable to hypertension and chronic kidney disease. RESULTS: The association between chronic kidney disease and renal cell carcinoma differed markedly by race (Pinteraction < 0.001), with associations observed among blacks (OR = 10.4 [95% CI = 6.0-17.9]), Asians (5.1 [2.2-11.7]), and Hispanics (2.3 [1.1-4.6]) but not whites (1.1 [0.6-1.9]). Hypertension, high BMI, and smoking were associated with renal cell carcinoma, but findings generally did not differ by race. Relative to other racial/ethnic groups, blacks had the highest proportion of renal cell carcinoma incidence attributable to hypertension and chronic kidney disease (combined, PAR = 37%; hypertension only, PAR = 27%; chronic kidney disease, PAR = 10%). CONCLUSIONS: Our findings suggest that hypertension and chronic kidney disease likely have contributed to the observed excess in renal cell carcinoma incidence among blacks compared with whites.
BACKGROUND: The incidence of renal cell carcinoma in the United States differs by race/ethnicity. To better understand these disparities, we conducted a nested case-control study investigating renal cell carcinoma risk factors across racial/ethnic groups within the Kaiser Permanente Northern California health care network. METHODS: Our study included 3136 renal cell carcinoma cases (2152 whites, 293 blacks, 425 Hispanics, and 255 Asians) diagnosed between 1998 and 2008 and 31031 individually matched controls (21478 whites, 2836 blacks, 4147 Hispanics, and 2484 Asians). Risk of renal cell carcinoma was assessed in relation to smoking status, body mass index (BMI), hypertension, and chronic kidney disease. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using conditional logistic regression, and population attributable risk (PAR) to estimate by race the proportion of cases attributable to hypertension and chronic kidney disease. RESULTS: The association between chronic kidney disease and renal cell carcinoma differed markedly by race (Pinteraction < 0.001), with associations observed among blacks (OR = 10.4 [95% CI = 6.0-17.9]), Asians (5.1 [2.2-11.7]), and Hispanics (2.3 [1.1-4.6]) but not whites (1.1 [0.6-1.9]). Hypertension, high BMI, and smoking were associated with renal cell carcinoma, but findings generally did not differ by race. Relative to other racial/ethnic groups, blacks had the highest proportion of renal cell carcinoma incidence attributable to hypertension and chronic kidney disease (combined, PAR = 37%; hypertension only, PAR = 27%; chronic kidney disease, PAR = 10%). CONCLUSIONS: Our findings suggest that hypertension and chronic kidney disease likely have contributed to the observed excess in renal cell carcinoma incidence among blacks compared with whites.
Authors: Claire M Vajdic; Stephen P McDonald; Margaret R E McCredie; Marina T van Leeuwen; John H Stewart; Matthew Law; Jeremy R Chapman; Angela C Webster; John M Kaldor; Andrew E Grulich Journal: JAMA Date: 2006-12-20 Impact factor: 56.272
Authors: P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle Journal: Lancet Date: 1999-07-10 Impact factor: 79.321
Authors: Jeffrey A Cutler; Paul D Sorlie; Michael Wolz; Thomas Thom; Larry E Fields; Edward J Roccella Journal: Hypertension Date: 2008-10-13 Impact factor: 10.190
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie Journal: Nephrol Dial Transplant Date: 2009-07-08 Impact factor: 5.992
Authors: Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Julie J Ruterbusch; Brian M Shuch; Sara Karami; Nathaniel Rothman; Sholom Wacholder; Barry I Graubard; Joanne S Colt; Mark P Purdue Journal: Cancer Causes Control Date: 2012-11-21 Impact factor: 2.506
Authors: Jung Eun Lee; David J Hunter; Donna Spiegelman; Hans-Olov Adami; Demetrius Albanes; Leslie Bernstein; Piet A van den Brandt; Julie E Buring; Eunyoung Cho; Aaron R Folsom; Jo L Freudenheim; Edward Giovannucci; Saxon Graham; Pamela L Horn-Ross; Michael F Leitzmann; Marjorie L McCullough; Anthony B Miller; Alexander S Parker; Carmen Rodriguez; Thomas E Rohan; Arthur Schatzkin; Leo J Schouten; Mikko Virtanen; Walter C Willett; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner Journal: J Natl Cancer Inst Date: 2007-05-16 Impact factor: 13.506
Authors: John H Stewart; Gherardo Buccianti; Lawrence Agodoa; Ryszard Gellert; Margaret R E McCredie; Albert B Lowenfels; Alex P S Disney; Robert A Wolfe; Peter Boyle; Patrick Maisonneuve Journal: J Am Soc Nephrol Date: 2003-01 Impact factor: 10.121
Authors: Jonathan N Hofmann; Douglas A Corley; Joanne S Colt; Brian Shuch; Wong-Ho Chow; Mark P Purdue Journal: Epidemiology Date: 2015-07 Impact factor: 4.822
Authors: Catherine L Callahan; Jonathan N Hofmann; Douglas A Corley; Wei K Zhao; Brian Shuch; Wong-Ho Chow; Mark P Purdue Journal: Cancer Epidemiol Date: 2018-07-18 Impact factor: 2.984
Authors: Rebecca E Graff; Alejandro Sanchez; Deirdre K Tobias; Dayron Rodríguez; Glen W Barrisford; Michael L Blute; Yanping Li; Qi Sun; Mark A Preston; Kathryn M Wilson; Eunyoung Cho Journal: Diabetes Care Date: 2018-04-20 Impact factor: 19.112
Authors: Catherine L Callahan; Kendra Schwartz; Douglas A Corley; Julie J Ruterbusch; Wei K Zhao; Brian Shuch; Barry I Graubard; Nathaniel Rothman; Wong-Ho Chow; Debra T Silverman; Mark P Purdue; Jonathan N Hofmann Journal: Cancer Causes Control Date: 2019-11-28 Impact factor: 2.506
Authors: Abiodun Mafolasire; Xiaopan Yao; Cayce Nawaf; Alfredo Suarez-Sarmiento; Wong-Ho Chow; Wei Zhao; Douglas Corley; Jonathan N Hofmann; Mark Purdue; Adebowale J Adeniran; Brian Shuch Journal: Cancer Med Date: 2016-05-26 Impact factor: 4.452